a) Exenatide b) Liraglutide c) Dulaglutide d) Semaglutide Answer: d) Semaglutide Cardiovascular benefits of GLP-1 agonists are most evident in: a) Type 1 diabetes b) Type 2 diabetes with CV risk c) Healthy adults d) Children Answer: b) Type 2 diabetes with CV risk GLP-1 receptor agonists delay: a) Insulin action b) Glucose absorption c) Gastric emptying d) Renal excretion Answer: c) Gastric emptying Pancreatitis is a: a) Common effect b) Contraindication c) Rare adverse effect d) Desired action Answer: c) Rare adverse effect Main site of GLP-1 receptor action for appetite regulation is: a) Pancreas b) Liver c) Hypothalamus d) Kidney Answer: c) Hypothalamus Liraglutide is FDA-approved for: a) Anemia b) Depression c) Weight loss d) Osteoporosis Answer: c) Weight loss FAQs 1
This guide breaks down the pros and cons of each, helping you make an informed decision about which option is best for your body and goals
Ozempic showed low hypoglycemia risk as monotherapy
Key Benefits: Broad-spectrum SPF 50+ PA++++ Brightens and firms skin Soothes irritation Deep hydration Lightweight, non-greasy, no white cast Perfect for dry or sensitive skin APLB Glutathione Niacinamide Brightening Face Sunscreen SPF50+ PA++++ blends powerful protection with premium skincare
That means a much larger share of the dose is available to your tissues, and its available quickly
#Semaglutide #DiabetesCare #ObesityManagement #PharmaIndustry #HealthcareInnovation #IndiaPharma #GLP1 #BPharm To view or add a comment, sign in More Relevant Posts Wave Life Sciences saw its stock halved after WVE-007 delivered 14% visceral fat reduction but only 1% body weight loss exposing the body composition vs